Table 2 Reported cases of mesonephric adenocarcinoma in the uterine corpus
Case | Study | Age | Size(cm) | Mesonephric remnant | Location | Involvement of END | CA125 | CA19–9 |
|---|---|---|---|---|---|---|---|---|
1 | Yamamoto et al. [2] | 58 | 14 | Cervix | MYO (left lateral) | - | Normal | Normal |
2 | Ordi et al. [3] | 33 | 8 × 6 | - | MYO | - | 47 IU/mL | NA |
3 | Bagué et al. [4] | 37 | 3.5 | - | END | + | NA | NA |
4 | Marquette et al. [5] | 81 | 3.7 × 3.0 × 2.3 | NA | MYO (right lateral) | + | 55 kU/mL | NA |
5 | Wani et al. [6] | 73 | 8 × 7 | - | MYO | + | Normal | Normal |
6 | Kenny et al. [7] | NA | NA | cervix | corpus | NA | NA | NA |
7 | Wu et al. [8] | 55 | 3.5 × 2.5 × 2.0 | NA | MYO, endocervix, (lateral) | + | 163.8 U/mL | 193.6 U/mL |
8 | Wu et al. [8] | 62 | 8 × 7 × 3 | NA | MYO | NA | Normal | Normal |
9–15 | McFarland et al. [9] | NA | NA | - | END, subsequent to MYO | + | NA | NA |
16 | Kim et al. [10] | 66 | 2.5 × 2.0 | - | MYO (left anterolateral) | + | Normal | NA |
17 | Ando et al. (present case) | 61 | 8 × 6.5 | - | MYO (left posterolateral) | - | 389 U/mL | 785 U/mL |